Acrivon Therapeutics Inc
(ACRV)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 89,199 | 67,103 | 32,657 | 16,184 | 3,168 |
| Operating Income | -89,199 | -67,103 | -32,657 | -16,184 | -3,168 |
| Other Income | 8,643 | 6,715 | 1,490 | -59 | -2,138 |
| Pre-tax Income | -80,556 | -60,388 | -31,167 | -16,243 | -5,306 |
| Net Income Continuous | -80,556 | -60,388 | -31,167 | -16,243 | -5,306 |
| Net Income | $-80,556 | $-60,388 | $-31,167 | $-16,243 | $-5,306 |
| EPS Basic Total Ops | -2.38 | -2.74 | -7.56 | -9.32 | -3.70 |
| EPS Basic Continuous Ops | -2.38 | -2.74 | -7.56 | -9.32 | -3.70 |
| EPS Diluted Total Ops | -2.38 | -2.74 | -7.56 | -9.32 | -3.70 |
| EPS Diluted Continuous Ops | -2.38 | -2.74 | -7.56 | -9.32 | -3.70 |
| EPS Diluted Before Non-Recurring Items | -2.38 | -2.74 | -7.56 | -9.32 | N/A |
| EBITDA(a) | $-91,970 | $-69,890 | $-32,991 | $-16,147 | $-3,155 |